BENICAR

Benicar Adverse Events Reported to the FDA Over Time

How are Benicar adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Benicar, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Benicar is flagged as the suspect drug causing the adverse event.

Most Common Benicar Adverse Events Reported to the FDA

What are the most common Benicar adverse events reported to the FDA?

Hypotension	401 (2.16%)
Drug Ineffective	392 (2.11%)
Dizziness	376 (2.02%)
Blood Pressure Increased	301 (1.62%)
Diarrhoea	237 (1.28%)
Headache	225 (1.21%)
Renal Failure Acute	220 (1.18%)
Nausea	203 (1.09%)
Oedema Peripheral	185 (1%)
Dehydration	178 (.96%)
Dyspnoea	178 (.96%)
	Show More
Weight Decreased	175 (.94%)
Vomiting	168 (.9%)
Malaise	165 (.89%)
Fall	164 (.88%)
Blood Pressure Decreased	161 (.87%)
Hyperkalaemia	157 (.84%)
Asthenia	154 (.83%)
Fatigue	144 (.77%)
Hypertension	136 (.73%)
Loss Of Consciousness	127 (.68%)
Syncope	125 (.67%)
Drug Interaction	123 (.66%)
Condition Aggravated	117 (.63%)
Cough	115 (.62%)
Hyponatraemia	109 (.59%)
Chest Pain	104 (.56%)
Renal Failure	101 (.54%)
Renal Impairment	100 (.54%)
Pain In Extremity	99 (.53%)
Blood Pressure Systolic Increased	91 (.49%)
Overdose	85 (.46%)
Pruritus	85 (.46%)
Feeling Abnormal	84 (.45%)
Rash	84 (.45%)
Cerebrovascular Accident	82 (.44%)
Anaemia	79 (.43%)
Bradycardia	78 (.42%)
Palpitations	76 (.41%)
Hypoglycaemia	73 (.39%)
Blood Creatinine Increased	71 (.38%)
Insomnia	70 (.38%)
Death	69 (.37%)
Coeliac Disease	65 (.35%)
Angina Pectoris	64 (.34%)
Muscle Spasms	64 (.34%)
Somnolence	64 (.34%)
Atrial Fibrillation	62 (.33%)
Blood Pressure Fluctuation	62 (.33%)
Pneumonia	62 (.33%)
Abdominal Pain	61 (.33%)
Anxiety	61 (.33%)
Depression	61 (.33%)
Arthralgia	60 (.32%)
Hyperhidrosis	60 (.32%)
Pain	60 (.32%)
Platelet Count Decreased	60 (.32%)
Alopecia	59 (.32%)
Hypertensive Emergency	59 (.32%)
Myalgia	59 (.32%)
Shock	58 (.31%)
Weight Increased	58 (.31%)
Drug Administration Error	57 (.31%)
Liver Disorder	57 (.31%)
Angioedema	55 (.3%)
Blood Glucose Increased	55 (.3%)
Hypersensitivity	54 (.29%)
Pyrexia	54 (.29%)
Back Pain	53 (.29%)
Heart Rate Increased	52 (.28%)
Abdominal Pain Upper	51 (.27%)
Tachycardia	51 (.27%)
Drug Exposure During Pregnancy	50 (.27%)
Hypoaesthesia	50 (.27%)
Hypokalaemia	50 (.27%)
Interstitial Lung Disease	50 (.27%)
Myocardial Infarction	50 (.27%)
Paraesthesia	50 (.27%)
Alanine Aminotransferase Increased	48 (.26%)
Completed Suicide	48 (.26%)
Decreased Appetite	47 (.25%)
Aspartate Aminotransferase Increase...	46 (.25%)
Urinary Tract Infection	46 (.25%)
Thrombocytopenia	45 (.24%)
Vision Blurred	45 (.24%)
Heart Rate Decreased	44 (.24%)
Convulsion	43 (.23%)
Cardiac Arrest	42 (.23%)
Oligohydramnios	42 (.23%)
Orthostatic Hypotension	42 (.23%)
Treatment Noncompliance	42 (.23%)
Arrhythmia	41 (.22%)
Blood Potassium Increased	41 (.22%)
Caesarean Section	41 (.22%)
Cardio-respiratory Arrest	41 (.22%)
Drug Eruption	41 (.22%)
Dry Mouth	41 (.22%)
Renal Disorder	40 (.22%)
Tremor	40 (.22%)
Blood Urea Increased	39 (.21%)
Cardiac Failure	39 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Benicar, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Benicar is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Benicar

What are the most common Benicar adverse events reported to the FDA?

Neurological	1089 (5.86%)
Cardiac And Vascular Investigations	799 (4.3%)
Decreased And Nonspecific Blood Pre...	648 (3.49%)
Gastrointestinal Signs	626 (3.37%)
Renal Disorders	625 (3.36%)
Therapeutic And Nontherapeutic Effe...	594 (3.2%)
Electrolyte And Fluid Balance Condi...	558 (3%)
Epidermal And Dermal Conditions	543 (2.92%)
Cardiac Arrhythmias	500 (2.69%)
Respiratory	498 (2.68%)
Infections - Pathogen Unspecified	357 (1.92%)
	Show More
Injuries	320 (1.72%)
Medication Errors	316 (1.7%)
Gastrointestinal Motility And Defec...	298 (1.6%)
Hepatic And Hepatobiliary	281 (1.51%)
Physical Examination Topics	274 (1.47%)
Hematology Investigations	242 (1.3%)
Headaches	240 (1.29%)
Urinary Tract Signs	240 (1.29%)
Central Nervous System Vascular	238 (1.28%)
Coronary Artery	225 (1.21%)
Musculoskeletal And Connective Tiss...	223 (1.2%)
Muscle	220 (1.18%)
Vascular Hypertensive	210 (1.13%)
Renal And Urinary Tract Investigati...	192 (1.03%)
Hepatobiliary	179 (.96%)
Skin Appendage Conditions	178 (.96%)
Water, Electrolyte And Mineral	162 (.87%)
Lower Respiratory Tract Disorders	156 (.84%)
Glucose Metabolism Disorders	143 (.77%)
Joint	142 (.76%)
Lifestyle Issues	141 (.76%)
Appetite And General Nutritional	125 (.67%)
Metabolic, Nutritional And Blood Ga...	125 (.67%)
Allergic Conditions	122 (.66%)
Anxiety Disorders	122 (.66%)
Arteriosclerosis, Stenosis, Vascula...	122 (.66%)
Vascular	118 (.63%)
Cardiac Disorder Signs	117 (.63%)
Chemical Injury And Poisoning	117 (.63%)
Anemias Nonhemolytic And Marrow Dep...	104 (.56%)
Vision	103 (.55%)
Sleep Disorders	102 (.55%)
Fatal Outcomes	101 (.54%)
Suicidal And Self-injurious Behavio...	99 (.53%)
Bone And Joint Injuries	90 (.48%)
Gastrointestinal Inflammatory Condi...	85 (.46%)
Malabsorption Conditions	83 (.45%)
Angiedema And Urticaria	82 (.44%)
Depressed Mood Disorders	76 (.41%)
Enzyme	76 (.41%)
Oral Soft Tissue Conditions	72 (.39%)
Heart Failures	69 (.37%)
Movement Disorders	69 (.37%)
Hematological And Lymphoid Tissue T...	68 (.37%)
Platelet	63 (.34%)
Bronchial Disorders	61 (.33%)
Tongue Conditions	61 (.33%)
Upper Respiratory Tract Disorders	61 (.33%)
Body Temperature Conditions	60 (.32%)
Myocardial	60 (.32%)
Therapeutic Procedures And Supporti...	60 (.32%)
Bacterial Infectious	59 (.32%)
Acid-base	58 (.31%)
Obstetric And Gynecological Therape...	58 (.31%)
Bone And Joint Therapeutic Procedur...	57 (.31%)
Placental, Amniotic And Cavity Diso...	55 (.3%)
White Blood Cell	55 (.3%)
Seizures	53 (.29%)
Inner Ear And Viiith Cranial Nerve	51 (.27%)
Viral Infectious	51 (.27%)
Gastrointestinal Hemorrhages	50 (.27%)
Lipid Analyses	48 (.26%)
Deliria	47 (.25%)
Lipid Metabolism	44 (.24%)
Skin Vascular Abnormalities	44 (.24%)
Gallbladder	43 (.23%)
Procedural And Device Related Injur...	43 (.23%)
Salivary Gland Conditions	43 (.23%)
Gastrointestinal Conditions	42 (.23%)
Psychiatric	41 (.22%)
Vascular Therapeutic Procedures	41 (.22%)
Dental And Gingival Conditions	40 (.22%)
Eye	39 (.21%)
Gastrointestinal Neoplasms Malignan...	39 (.21%)
Neonatal And Perinatal Conditions	39 (.21%)
Gastrointestinal Ulceration And Per...	38 (.2%)
Product Quality Issues	38 (.2%)
Bone, Calcium, Magnesium And Phosph...	37 (.2%)
Embolism And Thrombosis	36 (.19%)
Hepatobiliary Therapeutic Procedure...	35 (.19%)
Mental Impairment	35 (.19%)
Nephropathies	35 (.19%)
Exocrine Pancreas Conditions	34 (.18%)
Urolithiases	34 (.18%)
Vascular Hemorrhagic	32 (.17%)
Bone Disorders	31 (.17%)
Musculoskeletal And Connective Tiss...	29 (.16%)
Pleural	29 (.16%)
Eye Therapeutic Procedures	28 (.15%)
Toxicology And Therapeutic Drug Mon...	28 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Benicar, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Benicar is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.